loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

SAHAJANAND MEDICAL TECHNOLOGIES IPO

CLOSES TODAY

IPO Details

15th Oct 2026
19th Oct 2026
43
₹ 14,061
₹ 327-344
₹ 475 Crore

Issue timeline

  • 15-19 Oct 2026
  • 21-Oct-2026
  • 22-Oct-2026
  • 22-Oct-2026
  • 23-Oct-2026

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

Sahajanand Medical Technologies was incorporated on September 30, 2001. The company is an R&D-driven; developer of Class III and Class C/D medical devices, focused on Vascular Intervention and Structural Heart solutions. Its portfolio includes coronary stents, balloons, TAVI, occluders, renal stents, and other specialized products
-
Name Designation
Jose Calle Gordo Chairperson & Non-Executive Director
Bhargav Dhirajlal Kotadia Managing Director & Chief Executive Officer
Dhirajlal Vallabhbhai Kotadia Chairman Emeritus & Non-Executive Director
Priyanka Dhirajlal Cohen Non-Executive Director
Sonalika Girdharilal Dhar Independent Director
Debasis Panigrahi Independent Director
Harvinder Pal Singh Independent Director
Abhishek Rajendrakumar Kabra Non-Executive Director

Objectives

To carry out the offer for sale of 27,644,231 equity shares of face value of Rs 1 each, by the selling shareholders
To achieve the benefits of listing the equity shares on the stock exchanges

Strengths & Risks

Strengths (3)

The company operates two R\&D facilities in India and Thailand. The Surat center is DSIR-recognized and ISO certified, while the Thailand facility holds Thai GMP and CE certifications

Risks (3)

The company’s manufacturing facilities face risks like quality issues, outdated machinery, and infrastructure disruptions, which may raise costs or impact operations and reputation

Financials

Frequently Asked Questions

What is the issue type for Sahajanand Medical Technologies Ltd.?

This IPO consists of an offer for sale of up to Rs 475.5 crore, of 13,822,116 shares.

The promoters of the company are Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust.

The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.

The price band of the IPO is Rs 327.0 - 344.0.

The IPO application opens on Oct 15, 2026 and closes on Oct 19, 2026.

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.